In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, scPharmaceuticals Inc’s stock clocked out at $3.18, down -3.34% from its previous closing price of $3.29. In other words, the price has decreased by -$3.34 from its previous closing price. On the day, 0.68 million shares were traded.
Ratios:
To gain a deeper understanding of SCPH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.89 and its Current Ratio is at 8.08. In the meantime, Its Debt-to-Equity ratio is 1.71 whereas as Long-Term Debt/Eq ratio is at 1.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on September 07, 2023, initiated with a Buy rating and assigned the stock a target price of $20.
On December 01, 2022, Cowen started tracking the stock assigning a Outperform rating and target price of $25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 13 ’24 when ORBIMED ADVISORS LLC bought 500,000 shares for $4.00 per share. The transaction valued at 2,000,000 led to the insider holds 5,806,670 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 5.26 while its Price-to-Book (P/B) ratio in mrq is 5.18.
Stock Price History:
Over the past 52 weeks, SCPH has reached a high of $6.20, while it has fallen to a 52-week low of $3.08. The 50-Day Moving Average of the stock is -5.94%, while the 200-Day Moving Average is calculated to be -22.24%.
Shares Statistics:
A total of 50.04M shares are outstanding, with a floating share count of 34.09M. Insiders hold about 31.88% of the company’s shares, while institutions hold 65.11% stake in the company.
